Clinical Trial Update: A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of P1101 in Chinese patients with polycythemia vera who are intolerant or resistant to hydroxyurea; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• P1101

Snippet

Sponsor: PharmaEssentia | Conditions: Polycythemia Vera | Phase 2 | Status: ACTIVE_NOT_RECRUITING